Moreover, the ROC curve also demonstrated that SNRPD2, SNRPD3, and EIF4A3 could efficiently predict the metastasis in MM patients (SNRPD2, P < 0.01, AUC = 0.76; SNRPD3, P < 0.01, AUC = 0.71; EIF4A3, P < 0.01, AUC = 0.77; Figures 5(b)–5(d)). Here, EIF4A3 is linked to Miyoshi myopathy.